How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's at
In these contexts, pain is much more than a sensation: It is a protective call to action. But pain that is too intense or long-lasting can be debilitating. So how does modern medicine soften the call?
As a neurobiologist and an anesthesiologist who study pain, this is a question we and other researchers have tried to answer. Science's understanding of how the body senses tissue damage and perceives it as pain has progressed tremendously over the past several years. It has become clear that there are multiple pathways that signal tissue damage to the brain and sound the pain alarm bell.
Interestingly, while the brain uses different pain signaling pathways depending on the type of damage, there is also redundancy to these pathways. Even more intriguing, these neural pathways morph and amplify signals in the case of chronic pain and pain caused by conditions affecting nerves themselves, even though the protective function of pain is no longer needed.
Painkillers work by tackling different parts of these pathways. Not every painkiller works for every type of pain, however. Because of the multitude and redundancy of pain pathways, a perfect painkiller is elusive. But in the meantime, understanding how existing painkillers work helps medical providers and patients use them for the best results.
A bruise, sprain or broken bone from an injury all lead to tissue inflammation, an immune response that can lead to swelling and redness as the body tries to heal. Specialized nerve cells in the area of the injury called nociceptors sense the inflammatory chemicals the body produces and send pain signals to the brain.
Common over-the-counter anti-inflammatory painkillers work by decreasing inflammation in the injured area. These are particularly useful for musculoskeletal injuries or other pain problems caused by inflammation such as arthritis.
Nonsteroidal anti-inflammatories like ibuprofen (Advil, Motrin), naproxen (Aleve) and aspirin do this by blocking an enzyme called COX that plays a key role in a biochemical cascade that produces inflammatory chemicals. Blocking the cascade decreases the amount of inflammatory chemicals, and thereby reduces the pain signals sent to the brain. While acetaminophen (Tylenol), also known as paracetamol, doesn't reduce inflammation as NSAIDs do, it also inhibits COX enzymes and has similar pain-reducing effects.
Prescription anti-inflammatory painkillers include other COX inhibitors, corticosteroids and, more recently, drugs that target and inactivate the inflammatory chemicals themselves.
Because inflammatory chemicals are involved in other important physiological functions beyond just sounding the pain alarm, medications that block them will have side effects and potential health risks, including irritating the stomach lining and affecting kidney function. Over-the-counter medications are generally safe if the directions on the bottle are followed strictly.
Corticosteroids like prednisone block the inflammatory cascade early on in the process, which is probably why they are so potent in reducing inflammation. However, because all the chemicals in the cascade are present in nearly every organ system, long-term use of steroids can pose many health risks that need to be discussed with a physician before starting a treatment plan.
Many topical medications target nociceptors, the specialized nerves that detect tissue damage. Local anesthetics, like lidocaine, prevent these nerves from sending electrical signals to the brain.
The protein sensors on the tips of other sensory neurons in the skin are also targets for topical painkillers. Activating these proteins can elicit particular sensations that can lessen the pain by reducing the activity of the damage-sensing nerves, like the cooling sensation of menthol or the burning sensation of capsaicin.
Because these topical medications work on the tiny nerves in the skin, they are best used for pain directly affecting the skin. For example, a shingles infection can damage the nerves in the skin, causing them to become overactive and send persistent pain signals to the brain. Silencing those nerves with topical lidocaine or an overwhelming dose of capsaicin can reduce these pain signals.
Nerve injuries, most commonly from arthritis and diabetes, can cause the pain-sensing part of the nervous system to become overactive. These injuries sound the pain alarm even in the absence of tissue damage. The best painkillers in these conditions are those that dampen that alarm.
Antiepileptic drugs, such as gabapentin (Neurontin), suppress the pain-sensing system by blocking electrical signaling in the nerves. However, gabapentin can also reduce nerve activity in other parts of the nervous system, potentially leading to sleepiness and confusion.
Antidepressants, such as duloxetine and nortriptyline, are thought to work by increasing certain neurotransmitters in the spinal cord and brain involved in regulating pain pathways. But they may also alter chemical signaling in the gastrointestinal tract, leading to an upset stomach.
All these medications are prescribed by doctors.
Opioids are chemicals found or derived from the opium poppy. One of the earliest opioids, morphine, was purified in the 1800s. Since then, medical use of opioids has expanded to include many natural and synthetic derivatives of morphine with varying potency and duration. Some common examples include codeine, tramadol, hydrocodone, oxycodone, buprenorphine and fentanyl.
Opioids decrease pain by activating the body's endorphin system. Endorphins are a type of opioid your body naturally produces that decreases incoming signals of injury and produces feelings of euphoria – the so-called 'runner's high.' Opioids simulate the effects of endorphins by acting on similar targets in the body.
Although opioids can decrease some types of acute pain, such as after surgery, musculoskeletal injuries like a broken leg or cancer pain, they are often ineffective for neuropathic injuries and chronic pain.
Because the body uses opioid receptors in other organ systems like the gastrointestinal tract and the lungs, side effects and risks include constipation and potentially fatal suppression of breathing. Prolonged use of opioids may also lead to tolerance, where more drug is required to get the same painkilling effect. This is why opioids can be addictive and are not intended for long-term use. All opioids are controlled substances and are carefully prescribed by doctors because of these side effects and risks.
Although cannabis has received a lot of attention for its potential medical uses, there isn't sufficient evidence available to conclude that it can effectively treat pain. Since the use of cannabis is illegal at the federal level in the U.S., high-quality clinical research funded by the federal government has been lacking.
Researchers do know that the body naturally produces endocannabinoids, a form of the chemicals in cannabis, to decrease pain perception. Cannabinoids may also reduce inflammation. Given the lack of strong clinical evidence, physicians typically don't recommend them over FDA-approved medications.
While sounding the pain alarm is important for survival, dampening the klaxon when it's too loud or unhelpful is sometimes necessary.
No existing medication can perfectly treat pain. Matching specific types of pain to drugs that target specific pathways can improve pain relief, but even then, medications can fail to work even for people with the same condition. More research that deepens the medical field's understanding of the pain pathways and targets in the body can help lead to more effective treatments and improved pain management.
This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Rebecca Seal, University of Pittsburgh and Benedict Alter, University of Pittsburgh
Read more:
How do drugs know where to go in the body? A pharmaceutical scientist explains why some medications are swallowed while others are injected
What is fentanyl and why is it behind the deadly surge in US drug overdoses? A medical toxicologist explains
Sepsis is one of the most expensive medical conditions in the world – new research clarifies how it can lead to cell death
Rebecca Seal receives funding from National Institutes of Health
Benedict Alter receives funding from National Institutes of Health, Foundation for Anesthesia Education and Research, and the International Anesthesia Research Society.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
Californian tests positive for plague after camping in Lake Tahoe area
A California resident tested positive for plague, health officials said. 'The individual is currently under the care of a medical professional and is recovering at home,' El Dorado County officials said in a news release. 'It's believed that the person may have been bitten by an infected flea while camping in South Lake Tahoe area. Health officials are investigating the situation.' The county said it had notified the California Department of Public Health about the case. No other information about the person or their condition was released. Plague is caused by bacteria from bites from fleas that picked up the bacteria from a rodent. However, household pets can bring plague-infected fleas into homes. Human cases of plague are very rare, but can be very serious. Symptoms usually appear following exposure to an infected animal or flea and can include fever, nausea, weakness, swollen lymph nodes or worse. A person in northern Arizona died last month from the plague. At least 15 people have died from plague since 2000, Centers for Disease Control and Prevention data show. However, the disease can be treated effectively with antibiotics if it's diagnosed early. 'Plague is naturally present in many parts of California, including higher elevation areas of El Dorado County,' Kyle Fliflet, El Dorado County's acting director of public health, said in the news release. 'It's important that individuals take precautions for themselves and their pets when outdoors, especially while walking, hiking and or camping in areas where wild rodents are present.' _____


New York Times
26 minutes ago
- New York Times
They Kindled Froggy Romance and Rescued Eggs to Save a Species in Mississippi
It didn't look good for the dusky gopher frog. By the early 2000s, scientists knew of fewer than 100 adults left at a single seasonal pond in southern Mississippi, and that population faced an imminent threat: The water kept drying up before the tadpoles turned into frogs, killing them. Then, to make things worse, a parasite hit. A few survivors were taken into captivity. They refused to mate. But two decades later, the frog's trajectory has turned around. While the species remains critically endangered and still relies on intensive interventions, its numbers have grown to around 600 adults, spread out over some 15 ponds and a handful of captive populations that now produce offspring. It's been a roller-coaster ride. Over the years, collaborators — from federal and state agencies, academia, zoos and other conservation organizations — have lived through crushing lows, dizzying highs and chronic worry over the three-inch frogs. There have been brushes with disaster, like when critical genetic diversity was saved by relocating two frogs at a crucial moment. There have been quixotic quests to kindle froggy romance: Entire ponds have been constructed at the Memphis Zoo to tempt captive populations into mating. 50 States, 50 Fixes is a series about local solutions to environmental problems. More to come this year. Not to mention the mundane logistics. Some of the most important work has to happen on frog time (at night) and in frog weather (pouring rain). A pond where the frogs have been released into the wild. Tony Cenicola/The New York Times A froglet going through metamorphosis. Tony Cenicola/The New York Times Frogs being released into the wild. Whitney Steinfeld/Memphis Zoo An adult frog. A pond built at the Memphis Zoo. Zoo frogs in an imitation burrow. Tony Cenicola/The New York Times Glen's Pond, named for the researcher who discovered dusky gopher frogs there. John Tupy, USFWS A tortoise in its burrow, which the frogs also like to use. Tony Cenicola/The New York Times Sinlan Poo at a pond where frogs are reintroduced to nature. Tony Cenicola/The New York Times Want all of The Times? Subscribe.
Yahoo
27 minutes ago
- Yahoo
Surf Bio Announces Peer-Reviewed Publication Demonstrating Feasibility of Subcutaneous Delivery of Ultra-Concentrated Biologics
Research conducted by Stanford University and published in Science Translational Medicine shows successful injection of protein formulations exceeding 500 mg/mL PALO ALTO, Calif., Aug. 20, 2025 /PRNewswire/ -- Surf Bio, a biopharmaceutical company transforming the delivery of antibodies and biologics, announced today that a peer-reviewed study conducted by researchers at Stanford University and published in Science Translational Medicine has demonstrated the feasibility of reformulating biologics for subcutaneous delivery at ultra-high concentrations. The study's lead author, Carolyn Jons, Ph.D., and collaborators reported that spray-dried microparticle formulations surpassed 500 mg/mL and were delivered through a standard 27-gauge needle at clinically relevant forces, marking a potential breakthrough in expanding access to infusion-only therapies. The paper, entitled, "Glassy Surfactants Enable Ultra-High Concentration Biologic Therapeutics," may be accessed via the following URL: "The research addresses one of the most persistent challenges in drug delivery: how to administer high-dose biologic therapies without the need for intravenous infusion," stated Dr. Jons. "Many existing protein-based therapies require hospital or clinic-based infusions due to their large volume, instability, or reconstitution requirements. This study describes a spray-drying process that converts protein formulations into microparticles suspended in a non-solvent liquid carrier, resulting in a stable, ready-to-inject solution that meets the viscosity and force thresholds for subcutaneous administration." "This research provides a critical foundation for our work at Surf Bio and highlights the significant potential of our SnapShot™ technology," said Bryan Mazlish, CEO of Surf Bio. "We're leveraging this licensed platform to help unlock subcutaneous administration for therapies that have historically required IV infusion. Our goal is to translate this innovation into ready-to-inject, patient-friendly formulations that reduce burden on the healthcare system while enabling self-administration at home." Importantly, the platform utilizes a polymer excipient that improves stability during spray drying and enhances the injectability of the final formulation. In preclinical models, these microparticles were shown to maintain protein activity and structure, achieving doses well beyond those currently accessible with drug products approved for subcutaneous delivery. The technology does not require any specialized delivery device and can be used with commercially available autoinjectors and standard fill-finish processes. About Surf Bio:Surf Bio is a biopharmaceutical company transforming the delivery of antibodies and biologics via its SnapShot™ technology platform. Powered by the Company's proprietary polymer, SnapShot enables the development of ultra-high concentration formulations of monoclonal antibodies (mAbs) and biologics that can be administered using a single, standard autoinjector shot. To date, in-vitro and in-vivo safety and efficacy data have demonstrated that SnapShot enables drug developers to produce very high concentration, subcutaneous formulations of novel mAbs and biologics. Surf Bio was launched by the founders of Bigfoot Biomedical and AGC to commercialize a breakthrough drug delivery technology developed in the Appel lab at Stanford University. For more information about Surf Bio, visit Contact for Surf Bio:Tiberend Strategic Advisors, Reissereiss@ View original content to download multimedia: SOURCE Surf Bio, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data